Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou5f1
|
ENSMUSG00000024406.10 | POU domain, class 5, transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_35509528_35509679 | Pou5f1 | 782 | 0.296675 | -0.19 | 1.5e-01 | Click! |
chr17_35505957_35506108 | Pou5f1 | 14 | 0.933688 | 0.16 | 2.3e-01 | Click! |
chr17_35504592_35504743 | Pou5f1 | 1351 | 0.197413 | -0.09 | 4.8e-01 | Click! |
chr17_35507588_35507739 | Pou5f1 | 181 | 0.849567 | 0.07 | 6.1e-01 | Click! |
chr17_35508008_35508209 | Pou5f1 | 626 | 0.444053 | -0.05 | 7.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_67618825_67619284 | 13.55 |
Cadm2 |
cell adhesion molecule 2 |
1439 |
0.51 |
chrX_152643367_152644550 | 12.70 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chrX_165326738_165328112 | 12.56 |
Glra2 |
glycine receptor, alpha 2 subunit |
32 |
0.99 |
chr6_77978407_77979215 | 11.99 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
739 |
0.71 |
chr13_20473087_20474265 | 11.57 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr8_54954519_54955779 | 10.88 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr3_76075315_76075943 | 10.41 |
Fstl5 |
follistatin-like 5 |
46 |
0.98 |
chr8_8656555_8657725 | 9.86 |
Efnb2 |
ephrin B2 |
4099 |
0.11 |
chr8_12398370_12398923 | 9.78 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr14_88470472_88471305 | 9.48 |
Pcdh20 |
protocadherin 20 |
458 |
0.86 |
chr16_77594640_77595970 | 8.97 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr16_42338101_42338699 | 8.96 |
Gap43 |
growth associated protein 43 |
2251 |
0.38 |
chr7_82871690_82872524 | 8.79 |
Mex3b |
mex3 RNA binding family member B |
4774 |
0.17 |
chr1_25228097_25229399 | 8.79 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
78 |
0.96 |
chr2_65934036_65934599 | 8.71 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
2452 |
0.32 |
chr2_65848718_65849208 | 8.65 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
3108 |
0.27 |
chr18_21422902_21423149 | 8.54 |
Gm22886 |
predicted gene, 22886 |
42094 |
0.15 |
chr2_158606690_158608449 | 8.50 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr16_39985449_39985644 | 8.21 |
Lsamp |
limbic system-associated membrane protein |
951 |
0.68 |
chr1_169747005_169748207 | 7.95 |
Rgs4 |
regulator of G-protein signaling 4 |
17 |
0.98 |
chr3_4796861_4798079 | 7.93 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr3_16940666_16941582 | 7.85 |
Gm26485 |
predicted gene, 26485 |
117812 |
0.07 |
chr9_41587766_41588181 | 7.81 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
204 |
0.89 |
chr1_81077232_81078427 | 7.68 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr15_78116860_78117881 | 7.61 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
2336 |
0.22 |
chr2_37516828_37517574 | 7.59 |
Gpr21 |
G protein-coupled receptor 21 |
575 |
0.47 |
chr11_108607827_108608389 | 7.59 |
Cep112 |
centrosomal protein 112 |
2881 |
0.32 |
chr3_17783692_17784517 | 7.49 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
5817 |
0.2 |
chr4_116223265_116224130 | 7.38 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr1_70725543_70726581 | 7.25 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
139 |
0.98 |
chr12_15813034_15813970 | 7.23 |
Trib2 |
tribbles pseudokinase 2 |
3283 |
0.19 |
chr2_6883618_6884699 | 7.00 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr15_25409748_25410224 | 6.93 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
3712 |
0.18 |
chr13_84905458_84906287 | 6.90 |
Gm4059 |
predicted gene 4059 |
68445 |
0.12 |
chr13_8207058_8207829 | 6.79 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
4521 |
0.2 |
chr3_17792584_17792950 | 6.63 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr5_103209022_103210413 | 6.60 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr12_52699339_52699808 | 6.58 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
190 |
0.95 |
chr4_13746200_13747057 | 6.55 |
Runx1t1 |
RUNX1 translocation partner 1 |
3192 |
0.37 |
chr3_26329790_26330404 | 6.54 |
A830092H15Rik |
RIKEN cDNA A830092H15 gene |
1053 |
0.5 |
chr2_18039562_18041859 | 6.44 |
A930004D18Rik |
RIKEN cDNA A930004D18 gene |
2973 |
0.14 |
chr3_110139298_110139994 | 6.39 |
Ntng1 |
netrin G1 |
3358 |
0.33 |
chr8_105469813_105470589 | 6.34 |
Tppp3 |
tubulin polymerization-promoting protein family member 3 |
791 |
0.45 |
chr3_13948583_13948940 | 6.19 |
Ralyl |
RALY RNA binding protein-like |
2350 |
0.42 |
chr2_80126598_80127760 | 6.14 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
1655 |
0.42 |
chr3_73067017_73067367 | 6.11 |
Gm20754 |
predicted gene, 20754 |
841 |
0.61 |
chr8_94268148_94268983 | 6.10 |
Nup93 |
nucleoporin 93 |
41 |
0.96 |
chr1_187998988_187999336 | 6.10 |
Esrrg |
estrogen-related receptor gamma |
1294 |
0.52 |
chr16_69469508_69470143 | 6.05 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
330556 |
0.01 |
chr13_83725791_83726324 | 6.02 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2049 |
0.22 |
chr1_42261716_42262224 | 5.95 |
Gm28175 |
predicted gene 28175 |
113 |
0.97 |
chr5_57723598_57724600 | 5.86 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr1_66176824_66177184 | 5.79 |
Map2 |
microtubule-associated protein 2 |
1454 |
0.52 |
chr9_36821403_36822795 | 5.71 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
235 |
0.9 |
chrX_166346283_166346827 | 5.71 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr14_39468995_39469474 | 5.65 |
Nrg3 |
neuregulin 3 |
3432 |
0.39 |
chr1_168676421_168677250 | 5.64 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
953 |
0.73 |
chrX_16910513_16911557 | 5.62 |
Ndp |
Norrie disease (pseudoglioma) (human) |
739 |
0.79 |
chr14_64590608_64591000 | 5.56 |
Mir124a-1 |
microRNA 124a-1 |
147 |
0.74 |
chr19_8838893_8839483 | 5.50 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chr8_112572299_112572848 | 5.49 |
Cntnap4 |
contactin associated protein-like 4 |
2518 |
0.32 |
chr8_67973559_67974885 | 5.49 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
352 |
0.89 |
chr9_21936647_21937476 | 5.46 |
Plppr2 |
phospholipid phosphatase related 2 |
28 |
0.94 |
chr3_5225104_5225624 | 5.44 |
Zfhx4 |
zinc finger homeodomain 4 |
3859 |
0.22 |
chr3_88217018_88217342 | 5.34 |
Gm25641 |
predicted gene, 25641 |
1484 |
0.16 |
chr3_88208985_88210116 | 5.33 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr16_43504464_43505047 | 5.31 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chrX_166348094_166348432 | 5.27 |
Gpm6b |
glycoprotein m6b |
3421 |
0.29 |
chr13_77046468_77046715 | 5.25 |
Slf1 |
SMC5-SMC6 complex localization factor 1 |
806 |
0.74 |
chr5_114279370_114279652 | 5.24 |
Foxn4 |
forkhead box N4 |
5704 |
0.15 |
chr2_52557337_52558561 | 5.22 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr9_113813101_113813610 | 5.21 |
Clasp2 |
CLIP associating protein 2 |
755 |
0.71 |
chr2_65565600_65566271 | 5.17 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr9_43069907_43070263 | 5.16 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
27453 |
0.17 |
chr10_21883302_21884037 | 5.16 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
1300 |
0.42 |
chr6_17750183_17750783 | 5.09 |
St7 |
suppression of tumorigenicity 7 |
1091 |
0.38 |
chr14_39471112_39471496 | 5.07 |
Nrg3 |
neuregulin 3 |
1362 |
0.61 |
chr12_119235620_119236481 | 5.07 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chr12_37880304_37881575 | 5.05 |
Dgkb |
diacylglycerol kinase, beta |
223 |
0.96 |
chr4_116404856_116405098 | 4.97 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
1009 |
0.55 |
chr4_109343931_109344459 | 4.96 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
942 |
0.57 |
chr9_75683375_75684591 | 4.94 |
Scg3 |
secretogranin III |
8 |
0.97 |
chr19_47018258_47018719 | 4.92 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
3335 |
0.15 |
chr15_18819282_18819740 | 4.91 |
Cdh10 |
cadherin 10 |
534 |
0.58 |
chr12_29533001_29533958 | 4.89 |
Myt1l |
myelin transcription factor 1-like |
94 |
0.96 |
chr10_49786487_49786915 | 4.89 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2053 |
0.25 |
chr3_116222523_116223160 | 4.88 |
Gm31651 |
predicted gene, 31651 |
22433 |
0.15 |
chr5_111421306_111422790 | 4.86 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr7_51624664_51625766 | 4.86 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
67 |
0.98 |
chr5_13399790_13400460 | 4.85 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
548 |
0.84 |
chr8_33747278_33748028 | 4.84 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr4_9270926_9271667 | 4.83 |
Clvs1 |
clavesin 1 |
159 |
0.96 |
chr15_76519928_76521866 | 4.81 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr16_90388047_90389721 | 4.79 |
Hunk |
hormonally upregulated Neu-associated kinase |
2871 |
0.22 |
chr8_47285815_47285966 | 4.78 |
Stox2 |
storkhead box 2 |
3472 |
0.3 |
chr12_52700044_52701597 | 4.78 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chrX_136590440_136591154 | 4.76 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
45 |
0.96 |
chr15_95525022_95525792 | 4.75 |
Nell2 |
NEL-like 2 |
2771 |
0.35 |
chr12_41485290_41486156 | 4.75 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
708 |
0.74 |
chr9_41585078_41585353 | 4.74 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2554 |
0.15 |
chr7_16134834_16135297 | 4.72 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4717 |
0.13 |
chr7_92234907_92236280 | 4.71 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr10_110454344_110454630 | 4.71 |
Nav3 |
neuron navigator 3 |
1717 |
0.42 |
chr4_102760289_102761654 | 4.71 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
446 |
0.87 |
chr8_54959609_54959940 | 4.71 |
Gm45263 |
predicted gene 45263 |
45 |
0.97 |
chr3_76077829_76078163 | 4.69 |
Fstl5 |
follistatin-like 5 |
2413 |
0.35 |
chr1_158362036_158363261 | 4.68 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr1_143641893_143642230 | 4.67 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
464 |
0.75 |
chr13_83737592_83739114 | 4.67 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr3_8509825_8511666 | 4.67 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr18_42897755_42897906 | 4.67 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
985 |
0.64 |
chr8_54954107_54954436 | 4.66 |
Gpm6a |
glycoprotein m6a |
572 |
0.72 |
chr1_153652756_153654124 | 4.65 |
Rgs8 |
regulator of G-protein signaling 8 |
415 |
0.8 |
chr13_44946654_44947258 | 4.64 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr8_93813011_93813513 | 4.64 |
4930488L21Rik |
RIKEN cDNA 4930488L21 gene |
460 |
0.77 |
chr6_47245031_47245738 | 4.64 |
Cntnap2 |
contactin associated protein-like 2 |
931 |
0.71 |
chr3_89225214_89225991 | 4.60 |
Thbs3 |
thrombospondin 3 |
425 |
0.52 |
chrX_95195580_95195768 | 4.60 |
Arhgef9 |
CDC42 guanine nucleotide exchange factor (GEF) 9 |
778 |
0.67 |
chr7_90386713_90387752 | 4.59 |
Sytl2 |
synaptotagmin-like 2 |
127 |
0.96 |
chr10_18469102_18470206 | 4.57 |
Nhsl1 |
NHS-like 1 |
234 |
0.95 |
chr11_36674582_36674982 | 4.56 |
Tenm2 |
teneurin transmembrane protein 2 |
2963 |
0.37 |
chr2_106697404_106697975 | 4.55 |
Mpped2 |
metallophosphoesterase domain containing 2 |
1835 |
0.42 |
chr5_27261637_27262396 | 4.53 |
Dpp6 |
dipeptidylpeptidase 6 |
41 |
0.98 |
chr10_127532001_127533071 | 4.53 |
Nxph4 |
neurexophilin 4 |
2023 |
0.18 |
chrX_23294952_23295287 | 4.53 |
Klhl13 |
kelch-like 13 |
1039 |
0.66 |
chr8_109245493_109246323 | 4.53 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr13_78194258_78194409 | 4.51 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2040 |
0.23 |
chr6_92480350_92481798 | 4.49 |
Prickle2 |
prickle planar cell polarity protein 2 |
318 |
0.93 |
chr10_90577565_90578158 | 4.49 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr15_98983254_98984205 | 4.42 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr11_34315006_34315399 | 4.41 |
Insyn2b |
inhibitory synaptic factor family member 2B |
380 |
0.85 |
chr18_65583033_65584701 | 4.40 |
Zfp532 |
zinc finger protein 532 |
70 |
0.95 |
chr1_32173438_32173903 | 4.40 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
783 |
0.74 |
chr12_5376777_5377685 | 4.38 |
2810032G03Rik |
RIKEN cDNA 2810032G03 gene |
1361 |
0.39 |
chr9_75610075_75610368 | 4.38 |
Tmod2 |
tropomodulin 2 |
854 |
0.52 |
chr10_12614437_12615357 | 4.36 |
Utrn |
utrophin |
66 |
0.99 |
chr3_4798346_4798833 | 4.36 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
119 |
0.97 |
chr13_88822801_88824341 | 4.35 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
1929 |
0.5 |
chr14_60380755_60381381 | 4.35 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr13_78196283_78196791 | 4.34 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
164 |
0.91 |
chr2_181769553_181769907 | 4.34 |
Myt1 |
myelin transcription factor 1 |
2218 |
0.24 |
chr17_91092075_91093120 | 4.33 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr13_83726534_83727321 | 4.31 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr8_109248831_109249717 | 4.30 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr8_109247005_109247806 | 4.30 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
2461 |
0.39 |
chr10_11081408_11082323 | 4.30 |
Grm1 |
glutamate receptor, metabotropic 1 |
385 |
0.89 |
chr9_110054589_110054957 | 4.29 |
Map4 |
microtubule-associated protein 4 |
2721 |
0.19 |
chr17_57770604_57771141 | 4.29 |
Cntnap5c |
contactin associated protein-like 5C |
1302 |
0.38 |
chr8_99414293_99414856 | 4.28 |
Cdh8 |
cadherin 8 |
1745 |
0.36 |
chr13_112289274_112289896 | 4.28 |
Ankrd55 |
ankyrin repeat domain 55 |
765 |
0.56 |
chr14_99521583_99522333 | 4.28 |
Gm41230 |
predicted gene, 41230 |
587 |
0.8 |
chr15_100872221_100872372 | 4.28 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
876 |
0.59 |
chrX_135995020_135995354 | 4.27 |
Arxes2 |
adipocyte-related X-chromosome expressed sequence 2 |
1363 |
0.36 |
chr14_111677526_111678136 | 4.27 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
1982 |
0.36 |
chr6_138420211_138420823 | 4.26 |
Lmo3 |
LIM domain only 3 |
935 |
0.55 |
chr13_28948354_28948958 | 4.25 |
Sox4 |
SRY (sex determining region Y)-box 4 |
5057 |
0.24 |
chr1_42709764_42710511 | 4.25 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
2085 |
0.24 |
chr2_97468266_97469202 | 4.24 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chr14_67236008_67239452 | 4.24 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr16_28752596_28753856 | 4.23 |
Fgf12 |
fibroblast growth factor 12 |
158 |
0.97 |
chr19_5096540_5096943 | 4.23 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
1641 |
0.15 |
chr14_76419153_76419898 | 4.22 |
Tsc22d1 |
TSC22 domain family, member 1 |
697 |
0.78 |
chr8_47287269_47287420 | 4.19 |
Stox2 |
storkhead box 2 |
2018 |
0.4 |
chr8_30923939_30924325 | 4.18 |
Gm45252 |
predicted gene 45252 |
79776 |
0.1 |
chrX_52914554_52915519 | 4.17 |
Phf6 |
PHD finger protein 6 |
2741 |
0.19 |
chr6_8949544_8950237 | 4.15 |
Nxph1 |
neurexophilin 1 |
214 |
0.97 |
chr1_25227210_25227473 | 4.13 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
1485 |
0.33 |
chr13_60125494_60126730 | 4.13 |
A530065N20Rik |
RIKEN cDNA A530046M15 gene |
16997 |
0.16 |
chr2_94245067_94246249 | 4.13 |
Mir670hg |
MIR670 host gene (non-protein coding) |
2320 |
0.21 |
chr5_20228356_20229007 | 4.11 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
495 |
0.83 |
chr18_72349127_72350542 | 4.11 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr5_7342956_7343453 | 4.10 |
Zfp804b |
zinc finger protein 804B |
1552 |
0.41 |
chr7_45784257_45784949 | 4.10 |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
66 |
0.88 |
chr5_8621588_8621754 | 4.08 |
Rundc3b |
RUN domain containing 3B |
1281 |
0.47 |
chr9_41377643_41378358 | 4.07 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1439 |
0.4 |
chr15_25410386_25410743 | 4.06 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
3134 |
0.19 |
chr15_25754177_25754669 | 4.05 |
Myo10 |
myosin X |
1444 |
0.48 |
chr14_77158757_77158908 | 4.03 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
2052 |
0.38 |
chr5_125327376_125327881 | 4.02 |
Scarb1 |
scavenger receptor class B, member 1 |
91 |
0.96 |
chr7_37768312_37768463 | 4.01 |
Zfp536 |
zinc finger protein 536 |
1237 |
0.54 |
chr1_66386552_66386869 | 4.00 |
Map2 |
microtubule-associated protein 2 |
235 |
0.94 |
chr1_72533122_72533871 | 4.00 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
3434 |
0.27 |
chr6_113501346_113502215 | 4.00 |
Prrt3 |
proline-rich transmembrane protein 3 |
38 |
0.94 |
chr1_146494200_146495557 | 3.99 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr2_180890379_180892235 | 3.98 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr10_49785211_49786117 | 3.97 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr3_13472022_13472431 | 3.97 |
Gm2464 |
predicted gene 2464 |
397 |
0.59 |
chr3_26332588_26333347 | 3.97 |
Nlgn1 |
neuroligin 1 |
507 |
0.68 |
chr14_122459815_122460898 | 3.96 |
Zic5 |
zinc finger protein of the cerebellum 5 |
335 |
0.81 |
chr11_103773284_103774731 | 3.95 |
Wnt3 |
wingless-type MMTV integration site family, member 3 |
143 |
0.95 |
chr3_125403648_125404947 | 3.95 |
Ndst4 |
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 |
207 |
0.97 |
chr4_17855846_17855997 | 3.94 |
Mmp16 |
matrix metallopeptidase 16 |
2328 |
0.45 |
chr9_41378412_41379411 | 3.93 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr12_27335477_27335766 | 3.93 |
Sox11 |
SRY (sex determining region Y)-box 11 |
6953 |
0.3 |
chr4_91380440_91381612 | 3.93 |
Elavl2 |
ELAV like RNA binding protein 1 |
4530 |
0.22 |
chr8_93813521_93813847 | 3.91 |
4930488L21Rik |
RIKEN cDNA 4930488L21 gene |
38 |
0.97 |
chr5_150261018_150262108 | 3.91 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr8_79829209_79829763 | 3.91 |
Gm45433 |
predicted gene 45433 |
25875 |
0.15 |
chr8_36096303_36096801 | 3.90 |
Prag1 |
PEAK1 related kinase activating pseudokinase 1 |
1691 |
0.38 |
chr1_3672280_3672498 | 3.90 |
Xkr4 |
X-linked Kx blood group related 4 |
891 |
0.55 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
4.4 | 13.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.1 | 9.3 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.9 | 8.7 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.6 | 7.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.5 | 15.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.3 | 6.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.0 | 6.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.0 | 5.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.0 | 15.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.9 | 5.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.8 | 3.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.8 | 17.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.7 | 13.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.6 | 6.6 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 11.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.6 | 3.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.5 | 11.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.5 | 4.4 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 4.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.4 | 4.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.4 | 7.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.3 | 9.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 5.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.3 | 5.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.3 | 2.5 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.3 | 8.9 | GO:0097264 | self proteolysis(GO:0097264) |
1.3 | 3.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.2 | 2.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.2 | 7.3 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.2 | 3.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.2 | 2.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.1 | 3.4 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.1 | 3.4 | GO:0001757 | somite specification(GO:0001757) |
1.1 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.1 | 8.8 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.0 | 3.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.0 | 9.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.0 | 3.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 3.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.0 | 4.8 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
1.0 | 2.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.0 | 1.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.0 | 3.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.9 | 4.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 2.8 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 2.8 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.9 | 1.8 | GO:0048880 | sensory system development(GO:0048880) |
0.9 | 2.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.9 | 4.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.9 | 2.7 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.9 | 2.7 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.9 | 1.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 2.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 8.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.9 | 5.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.9 | 4.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.9 | 3.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 6.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 1.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 1.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 2.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.8 | 2.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 5.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 5.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 2.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 6.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.8 | 2.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.8 | 2.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.8 | 4.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 3.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 2.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.7 | 2.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.7 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.7 | 2.2 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.7 | 2.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.7 | 5.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.7 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 2.8 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.7 | 2.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 3.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 1.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.7 | 2.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.7 | 5.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 1.3 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.7 | 3.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.7 | 2.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 1.3 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.6 | 1.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.6 | 1.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 1.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.6 | 3.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 1.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 4.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 3.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 0.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.7 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.6 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.6 | 1.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 1.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 1.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.6 | 5.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.6 | 1.7 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.6 | 1.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.6 | 13.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.6 | 47.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 6.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 1.1 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.5 | 2.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 2.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 2.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.5 | 1.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 4.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 2.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 6.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.5 | 3.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 1.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 2.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 0.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.5 | 1.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 2.8 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.5 | 0.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 1.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 3.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 0.4 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.4 | 0.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.4 | 21.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.4 | 4.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 1.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.4 | 1.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 1.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.4 | 2.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 3.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 3.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 3.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 1.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 1.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.4 | 1.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 2.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 1.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 0.8 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 3.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 1.2 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.4 | 0.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 1.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 0.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.8 | GO:2000987 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.4 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 1.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 2.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 1.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 0.7 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 1.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 0.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 1.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.4 | 1.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 2.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 1.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 1.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 1.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 1.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 3.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 2.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 1.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 3.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 2.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 2.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 2.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 7.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 1.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.6 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 3.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 2.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 5.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 3.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 0.9 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 0.9 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 1.8 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.3 | 2.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 1.8 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 3.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 2.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 6.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 0.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 2.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 0.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.6 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 4.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.3 | 0.3 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.3 | 1.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 8.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 0.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 18.8 | GO:0050905 | neuromuscular process(GO:0050905) |
0.3 | 0.3 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 3.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 2.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 1.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.6 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 1.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 1.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 2.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.8 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 0.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 0.8 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 1.3 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.3 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 1.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.3 | 0.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.3 | 0.3 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.3 | 0.8 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.3 | 0.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 1.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 2.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 4.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.7 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 2.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 1.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 5.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.2 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.2 | 1.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.2 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.2 | 1.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 6.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.9 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 1.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.8 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 1.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.6 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 3.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 1.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.4 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.6 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 2.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 0.8 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 3.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.8 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.2 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.6 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.2 | 1.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 0.5 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 3.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.5 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 4.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 1.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 9.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 1.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 3.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.5 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.2 | 1.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.2 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 2.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 2.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.9 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 2.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 4.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.8 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.1 | 0.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 1.9 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.1 | 0.1 | GO:1904468 | response to sodium arsenite(GO:1903935) negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.1 | 0.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.9 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 1.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 1.9 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.1 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.8 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.1 | GO:2000172 | branching morphogenesis of a nerve(GO:0048755) regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 3.1 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.6 | GO:0051904 | pigment granule transport(GO:0051904) |
0.1 | 0.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 1.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.6 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 2.7 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.7 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:1902946 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:0048563 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 1.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.5 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.2 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.3 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.1 | 0.3 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.1 | 0.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.4 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 1.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 1.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.9 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 1.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 1.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 1.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 1.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 3.9 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.5 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.4 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 1.4 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.1 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 0.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.3 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.7 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.1 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 1.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 2.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.8 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 1.3 | GO:0022037 | metencephalon development(GO:0022037) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.1 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 1.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.4 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.8 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.2 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.1 | 0.1 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 1.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 1.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0051284 | positive regulation of sequestering of calcium ion(GO:0051284) |
0.0 | 0.5 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.4 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 3.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.0 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.4 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 2.8 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.3 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0048619 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.8 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.6 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0008306 | associative learning(GO:0008306) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.0 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.5 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.2 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.2 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.1 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0021536 | diencephalon development(GO:0021536) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.0 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.0 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.0 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.2 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.0 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.3 | 18.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.8 | 18.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 3.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.3 | 5.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 4.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 11.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 23.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.9 | 7.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 6.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.9 | 5.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 5.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 2.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 1.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 10.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 18.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 6.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 1.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 2.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 26.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.6 | 1.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 2.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.6 | 3.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.6 | 2.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.5 | 1.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.5 | 3.3 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 29.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.5 | 6.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 16.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 14.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 2.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 6.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 4.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 3.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 1.5 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 4.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 10.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 1.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 5.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 1.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 0.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 8.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 3.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 31.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 4.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 3.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.1 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 1.3 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.2 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 9.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 26.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 2.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 2.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 11.4 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 3.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 11.1 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 9.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 4.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.8 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 14.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 3.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.3 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 3.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 7.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 3.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 3.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.7 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.8 | GO:0030135 | coated vesicle(GO:0030135) |
0.0 | 1.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 8.0 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 2.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.7 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 6.7 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.2 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 2.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 17.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.4 | 10.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.2 | 6.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.7 | 16.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.1 | 6.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.6 | 6.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.3 | 4.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 9.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 3.9 | GO:0055100 | adiponectin binding(GO:0055100) |
1.3 | 3.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.3 | 3.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 6.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.2 | 6.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.2 | 8.5 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 13.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 4.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 5.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.1 | 4.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 3.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.0 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 2.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 5.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.9 | 2.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.9 | 2.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.9 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 2.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 7.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 5.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 2.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 4.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 11.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.7 | 2.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.7 | 6.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 6.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.7 | 6.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 2.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.6 | 2.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 1.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 1.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 2.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 3.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 5.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 5.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 6.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 6.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 4.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 5.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 1.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 1.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 7.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 2.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 4.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 5.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 0.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 8.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.4 | 10.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 10.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 10.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 2.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 4.2 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 2.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 1.7 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 8.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 8.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 0.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 4.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 4.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 4.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 5.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 1.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 5.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 2.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 2.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 31.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 2.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 7.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 5.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 1.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 2.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 18.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 8.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 3.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 4.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 2.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 3.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 6.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.8 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 3.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.7 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 2.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 2.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 3.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 6.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.8 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 5.6 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 2.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 2.1 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 5.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 2.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.4 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.7 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 12.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 4.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 32.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 15.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 3.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 3.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 1.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 3.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 3.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.2 | GO:0052768 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.6 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.8 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.0 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 1.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 11.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.3 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 2.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 9.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 9.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 7.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 3.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 6.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 8.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 5.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 6.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 4.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 5.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 5.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 5.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 12.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 4.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 28.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 23.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 5.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 8.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 6.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 5.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 7.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 7.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 9.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 2.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.5 | 4.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 9.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 7.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 3.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 11.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 7.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 4.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 10.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 4.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 7.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 3.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 10.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 4.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 5.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 1.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 7.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 0.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 7.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 5.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.5 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 5.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 3.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 1.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 7.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |